The category of VSTM5 Activators represents a group of diverse chemicals that are theorized to interact with and modulate the activity of the VSTM5 protein. This protein, based on its role and structure within cells, could be influenced by various biochemical compounds. The activators in this class are characterized by their ability to enhance VSTM5 activity, either through direct interaction with the protein or indirectly by affecting associated cellular pathways. Direct activators are thought to bind to VSTM5, altering its structure or stability, or its interactions with other cellular components, thereby increasing its functional activity. Indirect activators, conversely, are believed to affect VSTM5 through their influence on related signaling pathways or cellular processes, thereby indirectly modulating the protein's activity. These might include pathways involving intracellular signaling molecules like cAMP or calcium ions, or specific kinase activities, each impacting the cellular environment and, consequently, the activity of VSTM5.
Within this class, the chemicals are diverse, ranging from small organic compounds to more complex biomolecules. Some are speculated to mimic natural ligands or substrates of VSTM5, interacting with active or binding sites on the protein. Others might function allosterically, binding to sites distinct from the active site and inducing a functional change. The indirect activators in this group are considered capable of influencing VSTM5 activity by altering phosphorylation states, affecting gene expression, or changing the protein's cellular localization. They might modulate the activity of kinases or phosphatases upstream of VSTM5, affect transcriptional levels, or alter cellular redox states. There's also the possibility that some chemicals within this class could synergistically interact, leading to a more pronounced effect on VSTM5 activation. This diverse range of mechanisms reflects the intricate nature of protein regulation in cells, where numerous pathways and molecular interactions converge to determine a protein's activity. The VSTM5 Activators thus represent a conceptual group of chemicals, each potentially playing a role in the modulation of VSTM5 within cellular environments.
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
파클리탁셀은 미세소관 안정화제로서 VSTM5를 간접적으로 증가시킬 수 있습니다. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542는 TGF-β 1형 수용체 키나아제(ALK5)의 선택적 억제제로, TGF-β 경로를 통해 VSTM5를 활성화할 가능성이 있습니다. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $87.00 $270.00 | 9 | |
LY2109761은 TGF-β 수용체 키나아제 ALK5와 ALK4의 이중 억제제로, TGF-β 경로를 통해 VSTM5를 상향 조절할 수 있습니다. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
라파마이신은 mTOR 경로를 억제하는 면역 억제제로, 잠재적으로 mTOR 관련 경로를 통해 VSTM5를 활성화할 수 있습니다. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
사이클로스포린 A는 면역 억제제로서 간접적으로 VSTM5를 증가시킬 수 있습니다. |